tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Krystal Biotech: Strong Financial Performance and Strategic Growth Initiatives Support Buy Rating
PremiumRatingsKrystal Biotech: Strong Financial Performance and Strategic Growth Initiatives Support Buy Rating
1M ago
Krystal Biotech Reports Strong Q2 2025 Results
Premium
Company Announcements
Krystal Biotech Reports Strong Q2 2025 Results
1M ago
Krystal Biotech price target lowered to $166 from $176 at Citi
Premium
The Fly
Krystal Biotech price target lowered to $166 from $176 at Citi
1M ago
Krystal Biotech reports Q2 EPS $1.29, consensus $1.44
PremiumThe FlyKrystal Biotech reports Q2 EPS $1.29, consensus $1.44
1M ago
Is KRYS a Buy, Before Earnings?
Premium
Pre-Earnings
Is KRYS a Buy, Before Earnings?
1M ago
Positive Phase 1 Trial Results for KB304 Bolster Buy Rating for Krystal Biotech Amidst Promising Market Potential
Premium
Ratings
Positive Phase 1 Trial Results for KB304 Bolster Buy Rating for Krystal Biotech Amidst Promising Market Potential
1M ago
Krystal Biotech’s Subsidiary Reports Positive Phase 1 Results
PremiumCompany AnnouncementsKrystal Biotech’s Subsidiary Reports Positive Phase 1 Results
1M ago
Krystal Biotech subsidiary announces results from Phase 1 study of KB304
Premium
The Fly
Krystal Biotech subsidiary announces results from Phase 1 study of KB304
1M ago
Krystal Biotech price target lowered to $192 from $193 at BofA
Premium
The Fly
Krystal Biotech price target lowered to $192 from $193 at BofA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100